不同效价噬菌体SAvB14的药效测定

Y. Horiuk
{"title":"不同效价噬菌体SAvB14的药效测定","authors":"Y. Horiuk","doi":"10.33245/2310-4902-2021-168-2-57-64","DOIUrl":null,"url":null,"abstract":"Treatment of bacterial infections with bacteriophages is one of the alternative methods. However, the use of freely dispersed bacteriophages for treatment causes their inactivation under physiological conditions. Therefore, it is important to consider the concentration of bacteriophages in phage therapy. The aim of study – to determine the optimal titer of bacteriophage Phage SAvB14 in the drug Fagomast for the effective treatment of subclinical mastitis in cows caused by Stapholococcus aureus var. bovis. For research to determine the optimal therapeutic dose of the bacteriophage drug Fagomast in vitro, groups of animals were formed on the principle of analogues. Controls were animals treated with an antibiotic-based drug according to the instructions for use. Cows of the first experimental group were used samples of the drug with a titer of Phage SAvB14 10-7 BFU/ml, the second experimental group with a titer of 10-8 BFU/ml and the third group – 10-9 BFU/ml. It was found that all batches of Fagomast (81.8 - 92.8%) show good therapeutic efficacy, but the duration of treatment of animals was different. When using the drug Fagomast with a phage titer of 10-9 BFU/ml, it is shorter by 1 day than cows that were injected with a phage titer of 10-8 BFU/ml and 1.5 days compared with cows of the first group, which were injected with a phage titer of 10-7 BFU/ml. The results of the therapeutic efficacy of Fagomast with a bacteriophage titer of 10-8 and 10-9 BFU/ml in the drug are confirmed by the reaction with Mastidine, which after 48 hours was assessed as doubtful, and after 72 hours – as negative, as with antibiotic treatment. The content of S. aureus in the secretion of cows 12 hours after administration of the drug with a phage titer of 10-9 BFU/ml decreased 6 times (P ≤ 0.05), and after 48 hours 40 times (P ≤ 0.05), and after 60 hours of therapy did not stand out at all. The titer of bacteriophages remained at the level of 10-7 BFU/ml, and when the number of susceptible bacteria decreased to zero it decreased by 2 orders of magnitude. Thus, it can be said that maintaining a higher concentration of phage virions leads to better distribution of phages in the breast, and thus to improved binding of phages to host cells and their destruction.\nKey words: bacteriophages, Staphylococcus aureus, phagotherapy, bacteriophage drug, mastitis, cows.","PeriodicalId":34230,"journal":{"name":"Naukovii visnik veterinarnoyi meditsini","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Determination of the drug Fagomast effectiveness with different titers of Phage SAvB14\",\"authors\":\"Y. Horiuk\",\"doi\":\"10.33245/2310-4902-2021-168-2-57-64\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Treatment of bacterial infections with bacteriophages is one of the alternative methods. However, the use of freely dispersed bacteriophages for treatment causes their inactivation under physiological conditions. Therefore, it is important to consider the concentration of bacteriophages in phage therapy. The aim of study – to determine the optimal titer of bacteriophage Phage SAvB14 in the drug Fagomast for the effective treatment of subclinical mastitis in cows caused by Stapholococcus aureus var. bovis. For research to determine the optimal therapeutic dose of the bacteriophage drug Fagomast in vitro, groups of animals were formed on the principle of analogues. Controls were animals treated with an antibiotic-based drug according to the instructions for use. Cows of the first experimental group were used samples of the drug with a titer of Phage SAvB14 10-7 BFU/ml, the second experimental group with a titer of 10-8 BFU/ml and the third group – 10-9 BFU/ml. It was found that all batches of Fagomast (81.8 - 92.8%) show good therapeutic efficacy, but the duration of treatment of animals was different. When using the drug Fagomast with a phage titer of 10-9 BFU/ml, it is shorter by 1 day than cows that were injected with a phage titer of 10-8 BFU/ml and 1.5 days compared with cows of the first group, which were injected with a phage titer of 10-7 BFU/ml. The results of the therapeutic efficacy of Fagomast with a bacteriophage titer of 10-8 and 10-9 BFU/ml in the drug are confirmed by the reaction with Mastidine, which after 48 hours was assessed as doubtful, and after 72 hours – as negative, as with antibiotic treatment. The content of S. aureus in the secretion of cows 12 hours after administration of the drug with a phage titer of 10-9 BFU/ml decreased 6 times (P ≤ 0.05), and after 48 hours 40 times (P ≤ 0.05), and after 60 hours of therapy did not stand out at all. The titer of bacteriophages remained at the level of 10-7 BFU/ml, and when the number of susceptible bacteria decreased to zero it decreased by 2 orders of magnitude. Thus, it can be said that maintaining a higher concentration of phage virions leads to better distribution of phages in the breast, and thus to improved binding of phages to host cells and their destruction.\\nKey words: bacteriophages, Staphylococcus aureus, phagotherapy, bacteriophage drug, mastitis, cows.\",\"PeriodicalId\":34230,\"journal\":{\"name\":\"Naukovii visnik veterinarnoyi meditsini\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Naukovii visnik veterinarnoyi meditsini\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33245/2310-4902-2021-168-2-57-64\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Naukovii visnik veterinarnoyi meditsini","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33245/2310-4902-2021-168-2-57-64","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

用噬菌体治疗细菌感染是一种替代方法。然而,使用自由分散的噬菌体进行治疗会导致它们在生理条件下失活。因此,在噬菌体治疗中,考虑噬菌体的浓度是很重要的。本研究的目的是确定药物Fagomast中噬菌体SAvB14的最佳效价,以有效治疗牛金黄色葡萄球菌变异引起的奶牛亚临床乳腺炎。为了研究噬菌体药物Fagomast的体外最佳治疗剂量,我们按照类似物的原理组成动物组。对照动物根据使用说明用抗生素类药物治疗。第一试验组奶牛使用噬菌体SAvB14滴度为10-7 BFU/ml的药物样品,第二试验组奶牛使用滴度为10-8 BFU/ml的药物样品,第三试验组奶牛使用滴度为10-9 BFU/ml的药物样品。结果表明,各批次(81.8 ~ 92.8%)均有较好的治疗效果,但对动物的治疗时间不同。使用噬菌体滴度为10-9 BFU/ml的Fagomast药物时,比注射噬菌体滴度为10-8 BFU/ml的奶牛短1天,比注射噬菌体滴度为10-7 BFU/ml的第一组奶牛短1.5天。噬菌体滴度为10-8和10-9 BFU/ml的Fagomast治疗效果的结果通过与Mastidine的反应得到证实,Mastidine在48小时后被评估为可疑,在72小时后被评估为阴性,与抗生素治疗一样。在噬菌体滴度为10-9 BFU/ml的情况下,给药12 h后奶牛分泌物中金黄色葡萄球菌的含量下降了6倍(P≤0.05),48 h后下降了40倍(P≤0.05),60 h后根本不明显。噬菌体滴度维持在10 ~ 7 BFU/ml水平,当感菌数降至0时,其滴度下降2个数量级。因此,可以说,维持较高的噬菌体病毒体浓度,可以使噬菌体在乳腺中更好地分布,从而改善噬菌体与宿主细胞的结合和破坏。关键词:噬菌体,金黄色葡萄球菌,吞噬治疗,噬菌体药物,乳腺炎,奶牛
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Determination of the drug Fagomast effectiveness with different titers of Phage SAvB14
Treatment of bacterial infections with bacteriophages is one of the alternative methods. However, the use of freely dispersed bacteriophages for treatment causes their inactivation under physiological conditions. Therefore, it is important to consider the concentration of bacteriophages in phage therapy. The aim of study – to determine the optimal titer of bacteriophage Phage SAvB14 in the drug Fagomast for the effective treatment of subclinical mastitis in cows caused by Stapholococcus aureus var. bovis. For research to determine the optimal therapeutic dose of the bacteriophage drug Fagomast in vitro, groups of animals were formed on the principle of analogues. Controls were animals treated with an antibiotic-based drug according to the instructions for use. Cows of the first experimental group were used samples of the drug with a titer of Phage SAvB14 10-7 BFU/ml, the second experimental group with a titer of 10-8 BFU/ml and the third group – 10-9 BFU/ml. It was found that all batches of Fagomast (81.8 - 92.8%) show good therapeutic efficacy, but the duration of treatment of animals was different. When using the drug Fagomast with a phage titer of 10-9 BFU/ml, it is shorter by 1 day than cows that were injected with a phage titer of 10-8 BFU/ml and 1.5 days compared with cows of the first group, which were injected with a phage titer of 10-7 BFU/ml. The results of the therapeutic efficacy of Fagomast with a bacteriophage titer of 10-8 and 10-9 BFU/ml in the drug are confirmed by the reaction with Mastidine, which after 48 hours was assessed as doubtful, and after 72 hours – as negative, as with antibiotic treatment. The content of S. aureus in the secretion of cows 12 hours after administration of the drug with a phage titer of 10-9 BFU/ml decreased 6 times (P ≤ 0.05), and after 48 hours 40 times (P ≤ 0.05), and after 60 hours of therapy did not stand out at all. The titer of bacteriophages remained at the level of 10-7 BFU/ml, and when the number of susceptible bacteria decreased to zero it decreased by 2 orders of magnitude. Thus, it can be said that maintaining a higher concentration of phage virions leads to better distribution of phages in the breast, and thus to improved binding of phages to host cells and their destruction. Key words: bacteriophages, Staphylococcus aureus, phagotherapy, bacteriophage drug, mastitis, cows.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信